Mocikat R
GSF-Institut für Molekulare Immunologie, Munich, Germany.
J Immunol Methods. 1999 May 27;225(1-2):185-9. doi: 10.1016/s0022-1759(99)00042-3.
Mouse/human chimeric antibodies can easily be generated by exchanging the immunoglobulin constant gene segments with human sequences in mouse hybridoma cells by gene targeting. This obviates the need to isolate the variable gene regions from the hybridoma and permits high-level expression of chimeric antibodies, because the production rate of the hybridoma is often maintained. Here we show that the efficiency of this strategy can be further improved by increasing the number of high-producer clones arising from a recombination experiment. In principle, antibody production can be enhanced by removing the selection marker genes from the targeted cells.
通过基因打靶在小鼠杂交瘤细胞中用人源序列替换免疫球蛋白恒定基因片段,可轻松产生小鼠/人嵌合抗体。这消除了从杂交瘤中分离可变基因区域的必要性,并允许嵌合抗体的高水平表达,因为杂交瘤的生产率通常得以维持。我们在此表明,通过增加重组实验产生的高产克隆数量,可进一步提高该策略的效率。原则上,通过从靶向细胞中去除选择标记基因可提高抗体产量。